Patent details

EP1865986 Title: ANTI-CTLA-4 ANTIBODY COMPOSITIONS

Basic Information

Publication number:
EP1865986
PCT Application Number:
PCT/US/2006/007555
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP067368126
PCT Publication Number:
WO/2006/096491
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTI-CTLA-4 ANTIBODY COMPOSITIONS
French Title of Invention:
COMPOSITIONS D'ANTICORPS ANTI-CTLA-4
German Title of Invention:
ANTI-CTLA-4-ANTIKÖRPERZUSAMMENSETZUNGEN
SPC Number:

Dates

Filing date:
02/03/2006
Grant date:
17/02/2016
EP Publication Date:
17/02/2016
PCT Publication Date:
14/09/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/12/2007
EP B1 Publication Date:
17/02/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
02/03/2018
Expiration date:
02/03/2026
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
02/03/2006
 
 

Name:
Pfizer Products Inc.
Address:
Eastern Point Road, Groton, CT 06340, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
09/03/2016
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
ABATE Justin Donald
Address:
United States (US)

2

Name:
MUTHURANIA Kevin Wamiti
Address:
United States (US)

3

Name:
ELLIOTT Carrie Marie
Address:
United States (US)

4

Name:
SINGH Satish Kumar
Address:
United States (US)

5

Name:
NEMA Sandeep
Address:
United States (US)

6

Name:
DAS Tapan Kanti
Address:
United States (US)

Priority

1

Priority Number:
659766 P
Priority Date:
08/03/2005
Priority Country:
United States (US)

2

Priority Number:
728165 P
Priority Date:
19/10/2005
Priority Country:
United States (US)

3

Priority Number:
752712 P
Priority Date:
20/12/2005
Priority Country:
United States (US)

4

Priority Number:
762456 P
Priority Date:
26/01/2006
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 39/395;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
08/02/2017
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
165 Euro
Payer:
MARKS & CLERK LLP
Filing date Document type Number of pages
31/07/2018 Outgoing Correspondence 1